Physician profile
Kathryn K Morcom
NPI 1821309030
$2,190.33
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $338 · 2021: $611 · 2022: $664 · 2023: $17.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $514.08 | 2019-2022 | |
| Abbvie INC. | $487.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $233.02 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $157.22 | 2020-2021 | |
| Allergan, INC. | $119.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.15 | 2019-2022 | |
| Lilly USA, LLC | $105.72 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.63 | 2022 | |
| Pfizer INC. | $57.03 | 2019-2022 | |
| Amarin Pharma, INC. | $54.93 | 2019-2020 | |
| Therapeuticsmd, INC. | $49.25 | 2020-2021 | |
| Neos Therapeutics, LP | $31.79 | 2019-2020 | |
| Phadia US INC. | $26.77 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $23.03 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $22.62 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.74 | 2021 | |
| Bausch Health US, LLC | $20.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.52 | 2019 | |
| Glaxosmithkline, LLC. | $18.88 | 2022 | |
| Dynavax Technologies Corporation | $17.77 | 2023 | Heplisav-B |
| Sanofi Pasteur INC. | $14.48 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Morcom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.